Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Harrow Health, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $272.30M | $199.61M | $130.19M | $88.59M | $72.48M | $48.87M | $51.16M | $41.37M | $26.77M | $19.94M |
| Revenue Growth? | +36.4% | +53.3% | +47.0% | +22.2% | +48.3% | -4.5% | +23.7% | +54.5% | +34.3% | 0.0% |
| Cost of Revenue? | $67.93M | $49.24M | $39.64M | $25.38M | $18.21M | $14.46M | $16.75M | $16.52M | $13.51M | $9.83M |
| Gross Profit? | $204.37M | $150.37M | $90.55M | $63.21M | $54.26M | $34.41M | $34.42M | $24.85M | $13.27M | $10.11M |
| Gross Margin? | +75.1% | +75.3% | +69.6% | +71.3% | +74.9% | +70.4% | +67.3% | +60.1% | +49.6% | +50.7% |
| Operating Expenses? | $165.76M | $141.55M | $90.12M | $61.29M | $52.65M | $34.02M | $39.21M | $30.07M | $25.43M | $25.69M |
| Operating Income? | $38.61M | $8.82M | $431,000 | $1.92M | $1.61M | $385,000 | -$4.79M | -$5.22M | -$12.16M | -$15.88M |
| EBITDA? | $57.52M | $22.13M | $11.95M | $4.75M | $5.10M | $2.62M | $1.91M | -$3.37M | -$10.40M | -$14.17M |
| Income Before Tax | -$1.72M | -$17.32M | -$23.71M | -$14.01M | -$17.87M | -$3.42M | -$117,000 | $14.63M | -$12.92M | -$19.20M |
| Income Tax Expense | $3.42M | $161,000 | $701,000 | $75,000 | $133,000 | $4,000 | $8,000 | $0 | -$935,000 | -$111,000 |
| Net Income? | -$5.14M | -$17.48M | -$24.41M | -$14.09M | -$18.01M | -$3.36M | $168,000 | $14.63M | -$11.98M | -$19.09M |
| EPS? | $-0.14 | $-0.49 | $-0.75 | $-0.51 | $-0.69 | $-0.13 | $0.01 | $0.67 | $-0.60 | $-1.50 |
| Diluted EPS? | $-0.14 | $-0.49 | $-0.75 | $-0.51 | $-0.69 | $-0.13 | $0.01 | $0.61 | $-0.60 | $-1.50 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality